As a new session of Congress approaches, state Medicaid administrators and health plans have two main priorities they would like to see addressed in the 116th Congress: the ability to leave some prescription drugs off their formularies and development of a new payment model for expensive, curative drugs such as gene therapies. However, they are skeptical about how much policy progress can be made with a divided Congress. Massachusetts’ Medicaid program asked CMS for permission to leave certain drugs off...